Tuoxin Pharmaceutical announced that as of July 23, 2026, the controlling shareholder, actual controller and chairman Yang Xining, senior manager Ma Guanxing, and key executive Shao Yanxing increased their holdings of the company's shares by a total of 99,900 shares through centralized bidding transactions, accounting for 0.0789% of the company's total share capital, with a cumulative increase of 2,2294 million yuan. The total amount of the proposed increase in holdings of this plan is not less than 6 million yuan, not more than 12 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.